BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19397112)

  • 1. Breast cancer and "chemobrain": the consequences of cognitive difficulties following chemotherapy and the potential for recovery.
    Reid-Arndt SA
    Mo Med; 2009; 106(2):127-31. PubMed ID: 19397112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renaming "chemobrain".
    Hurria A; Somlo G; Ahles T
    Cancer Invest; 2007 Sep; 25(6):373-7. PubMed ID: 17882646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurocognitive changes in cancer survivors.
    Correa DD; Ahles TA
    Cancer J; 2008; 14(6):396-400. PubMed ID: 19060604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive function, fatigue, and menopausal symptoms in breast cancer patients receiving adjuvant chemotherapy: evaluation with patient interview after formal assessment.
    Downie FP; Mar Fan HG; Houédé-Tchen N; Yi Q; Tannock IF
    Psychooncology; 2006 Oct; 15(10):921-30. PubMed ID: 16477674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential for neuropsychology to inform functional outcomes research with breast cancer survivors.
    Reid-Arndt SA
    NeuroRehabilitation; 2006; 21(1):51-64. PubMed ID: 16720938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
    Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Women's experiences of cognitive changes or 'chemobrain' following treatment for breast cancer: a role for occupational therapy?
    Player L; Mackenzie L; Willis K; Loh SY
    Aust Occup Ther J; 2014 Aug; 61(4):230-40. PubMed ID: 24499127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's perceptions of chemotherapy-induced cognitive side affects on work ability: a focus group study.
    Munir F; Burrows J; Yarker J; Kalawsky K; Bains M
    J Clin Nurs; 2010 May; 19(9-10):1362-70. PubMed ID: 20500346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive adverse effects of chemotherapy in breast cancer patients.
    Correa DD; Ahles TA
    Curr Opin Support Palliat Care; 2007 Apr; 1(1):57-62. PubMed ID: 18660726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive impairments associated with breast cancer treatments: results from a longitudinal study.
    Quesnel C; Savard J; Ivers H
    Breast Cancer Res Treat; 2009 Jul; 116(1):113-23. PubMed ID: 18629633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction following adjuvant chemotherapy for breast cancer: two case studies.
    Paraska K; Bender CM
    Oncol Nurs Forum; 2003; 30(3):473-8. PubMed ID: 12719746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of priming and pre-existing knowledge of chemotherapy-associated cognitive complaints on the reporting of such complaints in breast cancer patients.
    Schagen SB; Das E; van Dam FS
    Psychooncology; 2009 Jun; 18(6):674-8. PubMed ID: 19021129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of a longitudinal study of changes in cognitive function in breast cancer patients undergoing chemotherapy with doxorubicin and cyclophosphamide.
    Jansen CE; Dodd MJ; Miaskowski CA; Dowling GA; Kramer J
    Psychooncology; 2008 Dec; 17(12):1189-95. PubMed ID: 18506671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update).
    Grunfeld E; Dhesy-Thind S; Levine M;
    CMAJ; 2005 May; 172(10):1319-20. PubMed ID: 15883407
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognitive problems after chemotherapy for breast cancer.
    Harv Womens Health Watch; 2002 Oct; 10(2):5-6. PubMed ID: 12393318
    [No Abstract]   [Full Text] [Related]  

  • 18. Cognitive function in breast cancer survivors.
    Vardy J
    Cancer Treat Res; 2009; 151():387-419. PubMed ID: 19593525
    [No Abstract]   [Full Text] [Related]  

  • 19. Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.
    Boykoff N; Moieni M; Subramanian SK
    J Cancer Surviv; 2009 Dec; 3(4):223-32. PubMed ID: 19760150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two different sides of 'chemobrain': determinants and nondeterminants of self-perceived cognitive dysfunction in a prospective, randomized, multicenter study.
    Hermelink K; Küchenhoff H; Untch M; Bauerfeind I; Lux MP; Bühner M; Manitz J; Fensterer V; Münzel K
    Psychooncology; 2010 Dec; 19(12):1321-8. PubMed ID: 20127909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.